Vaxcyte, Inc. — Director's Dealing 2021

Dec 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-12-27

Reporting Person: PICKERING GRANT (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-27	Common Stock	M	50365	$1.79	Acquired	630619	Direct
2021-12-27	Common Stock	M	1400	$2.03	Acquired	632019	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-27	Stock Option (right to buy)	$1.79	M	50365	Disposed	2027-05-17	Common Stock (50365)	Direct
2021-12-27	Stock Option (right to buy)	$2.03	M	1400	Disposed	2028-07-23	Common Stock (1400)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	355660	Indirect

Footnotes

F1: The shares subject to the option are fully vested and exercisable.

F2: 1/4 of the shares subject to the option vested on July 24, 2019, and 1/48 of the shares vest monthly thereafter.